Mdxhealth to Release First Quarter 2026 Financial Results on May 13
Rhea-AI Summary
Mdxhealth (NASDAQ: MDXH) will release its first-quarter 2026 financial results for the period ended March 31, 2026, after market close on May 13, 2026. The company will host a conference call and live Q&A the same day at 4:30pm ET / 22:30 CET (Conference ID: MDX1Q26).
Investors may join via dial-in numbers for the US, Belgium, and UK or watch the webcast at the provided URL; the webcast replay will be available on the company website.
Positive
- None.
Negative
- None.
News Market Reaction – MDXH
In the May 1 session, MDXH gained 0.98%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 16 | Clinical data update | Positive | -0.3% | New Oxford ProMPT study data showing GPS test predicts prostate cancer outcomes. |
| Feb 26 | Earnings release | Positive | -4.2% | Q4 and 2025 results with revenue growth, strong gross margin and improved EBITDA. |
| Feb 12 | Earnings date set | Neutral | -0.6% | Announcement of date and time for Q4 and full-year 2025 results call. |
| Jan 12 | Prelim results/guidance | Positive | +5.2% | Preliminary Q4 and 2025 revenues, 2026 guidance and amended Exact Sciences earnout. |
| Jan 06 | Clinical collaboration | Positive | -3.0% | Oxford ProtecT GPS validation initiative in large randomized prostate cancer trial. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history shows several instances where positive clinical or financial updates were followed by negative price reactions, with only one clearly positive reaction to upbeat revenue/guidance.
Over the last few months, MDXH has reported multiple milestones. Preliminary Q4 and 2025 revenues plus 2026 guidance on Jan 12 saw a positive reaction, while the detailed Q4 and full-year 2025 results on Feb 26 drew a negative move. Clinical collaborations and validation data releases on Jan 6 and Mar 16 also coincided with modest declines. A prior earnings date announcement on Feb 12 had limited impact. Today’s Q1 2026 earnings date fits this pattern of frequent, market-sensitive updates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Mdxhealth to Release First Quarter 2026 Financial Results on May 13
Company to Host Conference Call with Live Q&A, May 13, 2026, at 4:30pm ET / 22:30 CET
IRVINE, California – April 30, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the first quarter ended March 31, 2026, after market close on Wednesday, May 13, 2026.
| Title: | Mdxhealth Presents First Quarter 2026 Financial Results and Corporate Update Conference Call and Webcast |
| Date: | May 13, 2026 |
| Time: | 4:30pm ET/ 22:30 CET |
| Conference Call Dial-in Details: | United States: 1-800-245-3047 Belgium: 0800 72 519 United Kingdom: 0808 101 1183 |
| Conference ID: | MDX1Q26 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1758088&tp_key=21da6e9d38 |
The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website.
About Mdxhealth
Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests, based on proprietary genomic, epigenomic, exosomal and other molecular technologies, assist physicians with the diagnosis and prognosis of prostate cancer and other urologic diseases. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.
For more information:
LifeSci Advisors (IR & PR)
John Fraunces, Managing Director
Tel: +1 917 355 2395
jfraunces@lifesciadvisors.com
Attachment
FAQ
When will Mdxhealth (MDXH) report Q1 2026 financial results?
Direct answer: Mdxhealth will release Q1 2026 results after market close on May 13, 2026.
Context: According to the company, the results cover the quarter ended March 31, 2026 and will be followed by a conference call the same day.
What time is the Mdxhealth (MDXH) conference call and how can I join?
Direct answer: The conference call is set for 4:30pm ET / 22:30 CET on May 13, 2026.
Context: According to the company, participants can join via listed dial-in numbers or access the live webcast at the provided webcast URL; arrive 15 minutes early.
What is the Mdxhealth (MDXH) conference call access code and webcast link?
Direct answer: The conference ID is MDX1Q26 and the webcast URL is provided for the live event.
Context: According to the company, the webcast should be accessed 15 minutes before the call and a replay will be available on the company website after the live event.
Will there be a replay of the Mdxhealth (MDXH) Q1 2026 webcast?
Direct answer: Yes. A replay of the webcast will be available after the live call on the company website.
Context: According to the company, the live webcast will be accessible at the listed URL and a recording will remain posted for later viewing following the event.
Which dial-in numbers can I use to join the Mdxhealth (MDXH) May 13, 2026 call?
Direct answer: Dial-in numbers include a US toll-free line and regional numbers for Belgium and the United Kingdom.
Context: According to the company, the announcement lists US: 1-800-245-3047, Belgium: 0800 72 519, and UK: 0808 101 1183 for the call.